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Abstract 
 
Protein aggregation can lead to several incurable amyloidosis diseases. The full aggregation pathway is not 
fully understood, creating the need for new methods of studying this important biological phenomenon. 
Lysozyme is an amyloidogenic protein which is often used as a model protein for studying amyloidosis. This 
work explores the potential of employing Lysozyme encapsulated gold nanoclusters (Ly-AuNCs) to study the 
protein’s aggregation. The fluorescence emission properties of Ly-AuNCs were studied in the presence of 
increasing concentrations of native lysozyme and as a function of pH, of relevance in macromolecular 
crowding and inflammation-triggered aggregation. AuNC fluorescence was observed to both redshift and 
increase in intensity as pH is increased or when native lysozyme is added to a solution of Ly-AuNCs at pH 3. The 
long (s) fluorescence lifetime component of AuNC emission was observed to decrease under both conditions. 
Interestingly it was found via Time Resolved Emission Spectra (TRES) that both AuNC fluorescence components 
increase in intensity and redshift with increasing pH while only the long lifetime component of AuNC was 
observed to change when adding native lysozyme to solution; indicating that the underlying mechanisms for 
the changes observed are fundamentally different for each case. It is possible that the sensitivity of Ly-AuNCs 
to native lysozyme concentration could be utilized to study early stage aggregation. 
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Introduction 
 
Age related diseases such as Alzheimer’s have become more prevalent in well-developed countries over time 
as the life expectancy of the average citizen has increased[1]. With an increasingly aging population the 
likelihood of citizens developing Alzheimer’s is also increasing and as such the need to develop a better 
understanding of the underlying mechanisms, more effective therapeutics and preventative measures for an 
increasing number of sufferers is critical[2]. To develop effective treatments, it is first necessary to understand 
the cause of the disease. Several theories have been presented as to the cause of Alzheimer’s including head 
injury[3], infection[4], exposure to toxic substances[5] and incorrect immune system responses[6]. However, 
the theory that has gained the most support is the Amyloid Cascade hypothesis which proposes the formation 
of amyloid fibrils when the protein beta amyloid is deposited in the brain[7,8]. A fundamental understanding 
of protein aggregation is also vital in understanding the causes and developing therapeutics for other human 
diseases, including Huntington’s, Parkinson’s, Type II diabetes and several forms of cancer[9–12].  Although 
diverse in nature, these diseases are attributed to a complex aggregation of proteins that are normally 
soluble[13]. Much effort has been put into understanding the formation of amyloid fibrils, using different 
techniques including fluorescence spectroscopy with extrinsic probes such as thioflavin T (ThT)[14] or tyrosine 
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as an intrinsic probe[15], the development of computer simulations mimicking amyloid fibril formation[16] and 
solid state imaging of structure formation[17] by Nuclear Magnetic Resonance. However, new methods of 
observing the early stages of the fibril formation are still sorely needed as these could lead to a breakthrough 
in understanding and downstream benefits to healthcare. 
 
Protein encapsulated gold nanoclusters (AuNCs) are a new type of fluorescent nanoprobe which could be used 
to study early stage protein aggregation in addition to previous uses in metal ion, small molecule and enzyme 
detection[18–23]. These probes have been shown to be highly stable[24], non-photobleaching[25,26], and 
possess long lifetime fluorescence emission in the near red/near infrared[27]. They are also non-toxic and 
retain protein functionality after synthesis[21], making them ideal for studying protein aggregation with 
minimal probe perturbation. Lysozyme is an amyloidogenic protein which is often used as a model protein for 
studying amyloidosis[28]. Aggregation of lysozyme protein has been studied under various aggregation-
inducing conditions such as changing pH[29,30], increase in temperature[31] and interactions with aggregate 
inducing molecules such as guanidine hydrochloride and urea[32]. Previously lysozyme has been successfully 
used as a scaffold for AuNC (Ly-AuNCs) synthesis and as such opens questions as to whether AuNC 
fluorescence from Ly-AuNCs can be used to monitor lysozyme aggregation and better understand the 
formation of amyloid fibrils. A recent study found that macromolecular crowding in living cells significantly 
impacted on the structure of protein and led to its aggregation[33]. Moreover, there is growing body of 
evidence suggesting that inflammation plays an important role in the development of Alzheimer’s disease[34]. 
pH dependent aggregation is relevant in inflammation-triggered aggregation as well as in secondary nucleation 
of monomers in endosomes and other organelles of relevance to Parkinson’s disease[35].  Here, we studied 
the fluorescence emission properties of Ly-AuNCs in the presence of increasing concentrations of native 
lysozyme and as a function of pH. 
Materials and Methods 
 
Lysozyme (crystallized and lyophilized powder, from chicken egg white, (HEWL)), (≥99%) and Gold(III) 
Chloride Hydrate and Phosphate Buffer Solution in tablet form (PBS) were purchased from Sigma Aldrich while 
all other chemicals used during the study were purchased from Fluka and used without further purification. 
The synthesis of Lysozyme-AuNCs (Ly-AuNCs) was carried out using a modified version of Xie’s one-pot method 
by Wei et. al.[36]. Initially, a 5 ml solution of 10 mg ml-1 Lysozyme was mixed with a 5 ml solution of 4 mM 
HAuCl4 and 5 ml of H2O at 37 OC for 5 minutes. Next 0.5 ml of 1 M NaOH was added to the solution and 
incubated at 37 OC for 7 hours. The solution was then iincubated without stirring for a further 48 hours at 37 
OC. Ly-AuNCs were then dialysed into PBS buffer solution using 10kDa dialysis cassettes to remove any 
impurities from solution. The pH was altered using Hydrochloric acid and Sodium Hydroxide.  
 
Fluorescence emission spectra were measured using a HORIBA Fluorolog 3. Fluorescence lifetimes were 
measured using Time Correlated Single Photon Counting (TCSPC) with a HORIBA Deltaflex. For all 
measurements, a time range of 13 s was used with 482 nm HORIBA DeltaDiode laser excitation. All curves 
were measured until a peak count of 10,000 was obtained. Data were analysed using the DAS6 software 
package supplied by HORIBA. TRES and fluorescence anisotropy measurements were obtained using the same 
equipment and software package. The fluorescence intensity associated with a fluorescence decay 
component, i, was calculated from the product of the decay time i and the amplitude i obtained from the 
non-linear least-squares reconvolution analysis of the decay data.   
 
Results & Discussion 
 
Initially the fluorescence properties of Ly-AuNCs were studied at different pH values, the sample being excited 
at 470 nm (S.1 in supporting Information). The emission of AuNCs via 470 nm excitation produced an increase 
in fluorescence intensity at high pH compared to low pH and the peak emission wavelength was seen to red 
shift at high pH. The small intensity fluctuation in the pH range between 7-12 was mainly due to the 
experimental uncertainty.  The pH range between 3.5 – 6 was avoided in all the experiments due to the 
formation of large aggregates which are opaque[29]. The results for exciting at 470 nm are shown in Figure 1. 
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Figure 1: pH dependence of (a) fluorescence emission spectra, (b) peak fluorescence emission and (c) peak 
emission wavelength. The excitation wavelength is 470 nm. 
 
 
Previously, Cao et. al. observed the fluorescence changes in Bovine Serum Albumin (BSA) encapsulated AuNCs 
as a function of pH. It was found that the intensity of AuNC emission in the red spectrum regime increased 
progressively and the peak emission wavelength also increased between pH 2 – 11 while exciting at 500 
nm[37] The large red-shift in fluorescence emission due to pH has also previously been observed for BSA-
AuNCs by Wen et. al.[38]. The red-shift was attributed to the Quantum Confined Stark Effect (QCSE). QCSE is 
the shifting of electrons in a quantum well to lower discrete energy levels in the presence of an external 
electric field, while increasing the discrete hole states of a system to higher energies[39]. Due to the polar 
nature of the Ly-AuNC molecules and the highly negative zeta potential of Ly-AuNCs previously reported to be 
greater than negative 60 mV below pH 11[29] it is possible the redshift is governed by the polar characteristics 
of QCSE which have been observed arising in similar fluorescence quantum dot systems[40–42]. However, the 
fluorescence emission intensity would be expected to decrease if QCSE was the reason for the observed 
fluorescence red-shift for Ly-AuNCs. Wen et. al. have also observed a two-band fluorescence emission from 
BSA-AuNCs, describing the AuNC with a “core/shell ” fluorescence model derived from thiolate-protected Au25 
in which the core and shell are each responsible for a fluorescence band which makes up the red fluorescence 
peak[38,43,44]. This core/shell structure originates from the metal core state and surface states of the SR – Au 
– SR – Au – SR staples, respectively. AuNC in BSA binds to sulphur (S) atoms (via cysteine) but with a much 
(b) 
(a) 
(c) 
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reduced number than that in thiolate-protected Au25.[27] Although the exact atomic structure is unknown, S-
Au bonds (and possible bonds of gold to other neighbouring amino acids) form a motif that stabilizes the gold 
core.  It is plausible that two emission bands have different structural characteristics and different sensitivity 
to local environmental changes.  
 
The fluorescence lifetimes of protein encapsulated AuNCs are 2 exponential in nature[21,40,41], which 
compares well to the idea of a two band fluorescence emission model. To gain further understanding on the 
behaviour of Ly-AuNCs fluorescence due to changing pH, the fluorescence lifetimes of Ly-AuNCs were 
measured at different pH, excited directly at 482 nm and emission collected at 650 nm. At neutral pH, the 
fluorescence decay was found to be 2-exponential in nature; 2 long lifetimes associated with the fluorescence 
of the AuNCs of 1 = 2057 ± 7 ns and 2 = 723 ± 23 ns, similar to as previously reported from other AuNCs[27] 
plus one very fast component associated with scattered light from the sample itself. It was found from Figure 2 
that as pH is increased, the longer lifetime, 1, clearly decreases from 2.4 to 2.0 s, while 2 may show a small 
increase but remains within the uncertainty associated with the measurement. This has been previously 
observed in BSA-AuNCs[27] where changing pH results in protein unfolding, thus changing of local 
environment of the AuNCs. Lysozyme is more rigid but AuNC is more exposed to the solvent in comparison to 
that in HSA, and is therefore more sensitive to pH variation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Fluorescence lifetimes of Ly-AuNCs, 1 (a) and 2 (b), 
as a function of pH. Excitation wavelength 482 nm, emission 
wavelength 670 nm. 
 
 
Only one fluorescence lifetime component is observed to be significantly affected by changing pH. 
The increase in the fluorescence intensity correlated to the decrease of fluorescence lifetime suggests that this 
is not due to a reduced collisional quenching effect but possibly a mechanism of enhanced radiative process 
arising in a basic environment.  
 
To further understand the correlation between the two fluorescence components and the overall increase in 
intensity and redshift previously observed, TRES measurements were taken of Ly-AuNCs emission at pH 3 and 
pH 7, as shown in Figure 3.  Interestingly the TRES show both components increase in intensity and redshift, 
despite the decrease in fluorescence lifetime for the longer-lived fluorescence component. Previously, changes 
in the relative intensity of the two bands at different pH was observed[27].  TRES of Bovine Serum Albumin 
encapsulated AuNCs (BSA-AuNC) has shown two emission bands of 650 nm and 680 nm corresponding to  = 
2.40 s and  = 1.17 s at pH 12, and emission bands at 620 nm and 640 nm with corresponding to lifetimes of 
 = 4.46 s and  = 1.94 s[27] at pH 3.  
 
(a) (b) 
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Figure 3: TRES of Ly-AuNCs in solution at pH 3 and pH 7. The excitation wavelength is 482 nm. 
 
To test the sensitivity of Ly-AuNC fluorescence to native protein interactions, lysozyme was added to a solution 
of Ly-AuNCs and the fluorescence characteristics were observed. Two conditions of pH 3 and 12.5, were 
chosen due to them being either side of the isoelectric point of Ly-AuNCs and the fluorescence emission 
characteristics were monitored upon introducing increasing concentrations of native lysozyme to the solution. 
The Ly-AuNCs were excited at 470 nm and small increments of native lysozyme were added; the results are 
shown in Figure 4. 
 
 
 
Figure 4: Fluorescence emission spectrum maximum intensity of Ly-AuNCs (a) and fluorescence emission 
maximum wavelength (b) at different pH (pH 3 indicated in black, pH 12.5 indicated in red) as a function of 
native lysozyme addition in solution. The excitation wavelength is 470 nm. (Note that integrating the 
fluorescence intensity over all wavelengths showed similar trends). 
 
A small and gradual increase in fluorescence emission was observed at pH 3. A red-shift in fluorescence 
emission wavelength was observed upon first adding 5 mg/ml lysozyme to solution from 673 nm to 678 nm. 
Further increases in lysozyme concentration in solution yielded no clear further changes in fluorescence 
wavelength. No clear trend was evident for changes observed with the sample at pH 12.5. Clearly fluorescence 
emission intensity characteristics were not as sensitive or as unambiguous a method of probing 
protein/protein interactions where precipitation due to the formation of large aggregates results in changes in 
particle concentration. Therefore, fluorescence emission lifetimes were studied upon adding native lysozyme 
(a) (b) 
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to Ly-AuNCs to determine any sensitivity of Ly-AuNCs to protein/protein interactions at both pH 3 and pH 12.5. 
It was found that at pH 3 the longer fluorescence lifetime, 1, linearly decreased from 2.13 s to 1.85 s 
between 0-30 mg/ml added. No changes in 2 at pH 3 as lysozyme is added to the Ly-AuNCs solution were 
detected within the measurement error. At pH 12.5 both fluorescence lifetimes were observed to be 
unaffected by the addition of native lysozyme to the Ly-AuNCs solution. The results are shown in Figure 5. 
 
Figure 5: Fluorescence lifetimes of Ly-AuNCs as a function of added native lysozyme to solution and different 
pH. Ly-AuNCs 1 at pH 3 (a), Ly-AuNCs 2 at pH 3 (b), Ly-AuNCs 1 at pH 12.5 (c), Ly-AuNCs 2 at pH 12.5 (d). The 
excitation wavelength is 482 nm. 
 
 
Again, it is the longer lifetime component which is sensitive to environmental changes at pH 3. The lack of 
sensitivity at pH 12.5 suggests that the interaction between Ly-AuNCs and native lysozyme does not affect the 
micro-environment in which the AuNC is located within the lysozyme-AuNC complex. Time-resolved 
fluorescence anisotropy of the Ly-AuNCs at pH 3 and pH 12.5 in the presence and absence of native lysozyme 
was carried out to observe whether aggregation took place. Previous studies reported a loss of alpha helicity 
after the synthesis of encapsulated AuNC in lysozyme [46] and formation of dimmer [24]. The hydrodynamic 
radii of the Ly-AuNCs was found to be 3.73 ± 0.8 nm at pH 3 and 3.84 ± 0.52 nm at pH 12.5; comparing well 
with previously reported values[29]. An increase in the hydrodynamic radii to 6.49 ± 1.28 nm was observed 
upon adding 25 mg/ml of native lysozyme to Ly-AuNCs at pH 3. Interestingly, an increase in hydrodynamic 
radius to 5.86 ± 1.37nm at pH 12.5 was also observed. The difference in hydrodynamic radii indicates that the 
Ly-AuNCs and native lysozyme begin to form small initial aggregates of 2 – 4 protein molecules in size at pH 3 
and pH 12.5 in different conformations. This perhaps is not too surprising since Ly-AuNCs and lysozyme have a 
similar positive zeta potential at pH 3 whereas in highly basic conditions lysozyme has a weak negative zeta 
potential and Ly-AuNCs have a very strong negative zeta potential[29]. It has been previously shown by 
Burnett et. al. that environmental conditions affect the aggregate morphologies of lysozyme and as such 
supports the theory that the differences observed in fluorescence lifetimes for Ly-AuNCs under different pH 
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conditions may arise from different aggregation forms[42]. It is possible that the reason for a decrease in 1 at 
pH 3 is due to the binding of native lysozyme to Ly-AuNCs near the AuNC nucleation sites and shielding of 
AuNC from the acidic environment, thus resulting in enhancement of the radiative rate. To better understand 
the fluorescence mechanics when adding lysozyme to Ly-AuNCs at pH 3, the TRES of AuNCs was measured in 
the presence and absence of native lysozyme in solution, as shown in Figure 6. 
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Figure 6: Time resolved emission spectra of Ly-AuNCs in the presence and absence of native lysozyme in 
solution at pH 3. The excitation wavelength is 482 nm. 
 
 
From Figure 6 we can see that the longer lifetime 1 emission increases and redshifts, while the emission from 
2 remains unchanged; confirming that the smaller fluorescence increase and redshift seen previously in Figure 
4 can be directly attributed to the changes in the fluorescence emission of 1. Comparing this to the previous 
TRES measurements of Figure 3, we can see that while the changes in the fluorescence emission spectra and 
fluorescence emission lifetimes are similar for increasing pH and adding native lysozyme to solution, the 
underlying mechanism for these observations is different. In the case of increasing pH we observe a large 
intensity increase and redshift for both fluorescence components whereas upon adding native lysozyme to 
solution only 1 undergoes a slight increase in intensity and redshift. Previously we have observed that the 
diameter of Ly-AuNCs remains quite consistent at 8.0 nm across a pH range of 2-11 (with the exception of 
aggregates forming around the isoelectric point of Ly-AuNCs at pH 4[29]. Therefore, we can rule out the 
formation of aggregates as the reason for the observed fluorescence changes. It is more likely that the 
observed changes to both 1 and 2 are caused electrostatically, since the Ly-AuNC complex has been observed 
to become more negatively charged at higher pH. However, in the case of adding native lysozyme to the Ly-
AuNC solution, it is more plausible that the observed changes in fluorescence characteristics are due to the 
formation of small initial proto-aggregates of 2 – 4 proteins in size. Previously Siddiqui et. al. have shown the 
increase and redshift of intrinsic hemagloblin fluorescence upon macromolecular crowding and aggregation 
caused by bovine serum albumin (BSA) interaction[33]. Initial aggregate formation alone however did not 
result in changes to the fluorescence characteristics of AuNCs at pH 12.5 when adding native lysozyme, only at 
pH 3, therefore the aggregation morphology must play an important role since the morphology at pH 3 and pH 
12.5 can be expected to be different due to changes in protein surface charge and interaction of lysozyme[33]. 
Therefore, it seems likely that the changes to 1 only arise from a physical interaction of the AuNCs with the 
surrounding microenvironment due to initial aggregate induced conformational changes.   
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Conclusions 
 
Here we have presented the environmental induced effects of Ly-AuNCs fluorescence characteristics including 
fluorescence emission intensity, peak emission wavelength, fluorescence lifetime and time resolved emission. 
It was found that the fluorescence emission intensity and peak fluorescence wavelength of Ly-AuNCs increases 
and red-shifts upon changing pH from acidic to basic conditions when exciting the AuNC directly at 470 nm. 
The longer fluorescence lifetime component 1 was also seen to decrease in highly basic conditions. We have 
also reported the interaction between Ly-AuNCs and varying concentrations at different pH.  Clear changes to 
the fluorescence characteristics of Ly-AuNCs were observed at pH 3, with the fluorescence emission intensity 
increasing linearly with native lysozyme concentration, a small redshift in peak wavelength and a decrease in 
the 1 fluorescence lifetime. Conversely no clear trend was observed at pH 12.5 for Ly-AuNCs fluorescence. 
This is thought to be due to differences in the small aggregate morphology at pH 3 and pH 12.5 as Ly-AuNC-
native lysozyme proto-aggregates begin to form. Further studies are needed to determine the exact nature of 
Ly-AuNCs-native lysozyme proto-aggregate formations; however, these initial results show the sensitivity of 
Ly-AuNCs to environmental changes and early aggregation, which may be utilized in the future as a means of 
studying and modelling lysozyme aggregation. 
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